Skip to content

Urethral Vascularization and Urodynamics

UVASC Urethral Vascularization and Urodynamics

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07185698
Acronym
UVASC
Enrollment
70
Registered
2025-09-22
Start date
2025-09-01
Completion date
2026-06-30
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence, Ultrasound, Vascularisation, Urodynamic Exam

Brief summary

The urethra plays a crucial role in maintaining urinary continence. Its complex blood supply is still not well understood. Particularly in the context of urethral pressure. Urethral pressure can be measured by bladder and urethral pressure studies (urodynamic). This study aims to use advanced imaging techniques to analyse the blood supply of the urethra and correlate it to urethral pressure measurements. Elucidating these relationships will improve our understanding of urethral function and malfunction, and ultimately optimise diagnosis and treatment of stress urinary incontinence. A total of 35 participants with stress urinary incontinence and 35 without stress urinary incontinence will be asked to participate in this study.

Interventions

DIAGNOSTIC_TEST3D Ultrasound

Virtual Organ Computer-aided AnaLysis (VOCAL) to assess flow and velocity characteristics of the urethral blood supply

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Urodynamic examination * Written informed consent * Understanding of the German language * Indicated urodynamic assessment * Endovaginal and perineal ultrasound feasible

Exclusion criteria

* Urinary tract infections * Transgender Population * Pregnancy * History of incontinence or prolapse surgery * Pelvic prolapse higher than second degree * Prior pelvic radiotherapy * Prior history of gynecologic tumor

Design outcomes

Primary

MeasureTime frameDescription
Color histogram index (Vascularity Index)Enrollment by the urodynamic examination until the ultrasound measurement (VOCAL) up to 4 weeksDoppler Indices (Vascularity Index) generated by Virtual Organ Computer-aided AnaLysis (VOCAL)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026